Abstract
BackgroundAchieving remission is essential for avoiding joint destruction and disability in patients with rheumatoid arthritis (RA). Tumor necrosis factor inhibitors (TNFi) therapies represent an important advancement in therapy for RA....
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have